Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Drug discovery

Fat-free proteins kill parasites

Nature volume 464, pages 689–690 (2010)Cite this article

Subjects

The addition of a fatty acid to certain proteins is vital for the survival of protozoa that cause sleeping sickness and of their mammalian hosts. Compounds that target this process in the protozoa are now reported.

The T. brucei parasite is a small, unicellular organism with many biological similarities to its human host cells, but which has taken different routes in the evolution of certain critical cellular pathways. It also has some unique cellular pathways. There is therefore widespread optimism that it should be possible to develop treatments for HAT by identifying drug targets that are specific to the organism — assuming that the financial resources are available. What's more, T. brucei lives outside its host's cells (unlike its distant cousins Trypanosoma cruzi and the many varieties of Leishmania), which should facilitate drug development. The human immune system cannot eradicate T. brucei because the parasite has developed an apparently insurmountable capacity for antigenic variation. This allows HAT infections to persist until (usually) the death of the infected person, following the coma that occurs once the parasite invades the patient's brain.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Figure 1: A forgotten disease.

EYE OF SCIENCE/SPL; A. CRUMP, TDR, WHO/SPL

References

  1. Frearson, J. A. et al. Nature 464, 728–732 (2010).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  2. Resh, M. D. Nature Chem. Biol. 2, 584–590 (2006).

    Article  CAS  Google Scholar 

  3. Henderson, L. E., Krutzsch, H. C. & Oroszlan, S. Proc. Natl Acad. Sci. USA 80, 339–343 (1983).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  4. Price, H. P. et al. J. Biol. Chem. 278, 7206–7214 (2003).

    Article  CAS  PubMed  Google Scholar 

  5. Price, H. P., Guther, M. L. S., Ferguson, M. A. J. & Smith, D. F. Mol. Biochem. Parasitol. 169, 55–58 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Engstler, M. et al. Cell 131, 505–515 (2007).

    Article  CAS  PubMed  Google Scholar 

  7. http://www.drugdiscovery.dundee.ac.uk/index.html

  8. Frearson, J. A., Wyatt, P. G., Gilbert, I. H. & Fairlamb, A. H. Trends Parasitol. 23, 589–595 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. George A. M. Cross is at The Rockefeller University, New York, New York 10065-6399, USA. george.cross@rockefeller.edu ,

    George A. M. Cross

Authors
  1. George A. M. Cross
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cross, G. Fat-free proteins kill parasites. Nature 464, 689–690 (2010). https://doi.org/10.1038/464689a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/464689a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing